Live
One Link Live rooms, co-hosting, captions, gifts and community tools.

OneLinkUS
GHOST OMNI DIVINE IS GOD LLC
OneLinkUS.com
Sign in with an existing subscription to unlock visual layouts.
Browse worldwide headlines, search any country or region, and choose a topic. Publisher photographs and video appear when available from the news source.
Explore news by country, topic and format →Headlines from publishers around the world. Search any country, region or topic.
No headlines found. Try a broader topic.
More world news →7 results for “United States Engineered mesenchymal stem/stromal cells against cancer - Nature live news”
Showing OneLink and reference results. Broader web, photo and video coverage is awaiting the search provider connection.
One Link Live rooms, co-hosting, captions, gifts and community tools.
Worldwide problem-solving, official services, emergency guidance and reliable next steps.
Advanced platform connections, AI, backend and service status.
Stem-cell therapy uses stem cells to treat or prevent a disease or condition. As of 2024, the only FDA-approved therapy using stem cells is hematopoietic stem cell transplantation.
An organoid is a miniaturised and simplified version of an organ produced in vitro in three dimensions that mimics the key functional, structural, and biological complexity of that organ. It is derived from one or a few stem cells from a tissue, embryonic stem cells, or induced pluripotent stem cells, which can self-organize in three-dimensional culture owing to their self-renewal and differentiation capacities.
Cryopreservation or cryoconservation is a process where biological material—cells, tissues, or organs—are frozen to preserve the material for an extended period of time. At low temperatures (typically −80 °C (−112 °F) or −196 °C (−321 °F) using liquid nitrogen) any cell metabolism which might cause damage to the biological material in question is effectively stopped.
This article lists a number of significant events in science that have occurred in the first quarter of 2023.